Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Buhler P et al. - Although the diabody binds to all T-cells, only those in contact with PSMA-expressing cancer cells are activated. The PSMA×CD3 diabody is suitable for a controlled polyclonal T-cell therapy of prostate cancer.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address